GemPharmatech's comprehensive in vivo efficacy evaluation platform for antitumor drugs facilitates the development of immuno-oncology therapies. Our team can perform a variety of tests, including 14 marker flow cytometry, TIL analysis, small molecule testing, bioassays, and non-GLP toxicology studies.